FEV1Q: a race-neutral approach to assessing lung function

被引:0
|
作者
Balasubramanian, Aparna [1 ]
Wise, Robert A. [1 ]
Stanojevic, Sanja [2 ]
Miller, Martin R. [3 ]
McCormack, Meredith C. [1 ]
机构
[1] Johns Hopkins Sch Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA
[2] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada
[3] Univ Birmingham, Inst Appl Hlth Res, Birmingham, England
关键词
SPIROMETRIC REFERENCE VALUES; FORCED EXPIRATORY VOLUME; REFERENCE EQUATIONS; GENETIC ANCESTRY; US; RACE/ETHNICITY; OUTCOMES; DISEASE; ADULTS; FEV1;
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background Forced expiratory volume in 1 s quotient (FEV(1)Q) is a simple approach to spirometry interpretation that compares measured lung function to a lower boundary. This study evaluated how well FEV(1)Q predicts survival compared with current interpretation methods and whether race impacts FEV(1)Q. Methods White and Black adults with complete spirometry and mortality data from the National Health and Nutrition Examination Survey (NHANES) III and the United Network for Organ Sharing (UNOS) database for lung transplant referrals were included. FEV(1)Q was calculated as FEV1 divided by 0.4 L for females or 0.5 L for males. Cumulative distributions of FEV1 were compared across races. Cox proportional hazards models tested mortality risk from FEV(1)Q adjusting for age, sex, height, smoking, income and among UNOS individuals, referral diagnosis. Harrell's C -statistics were compared between absolute FEV1, FEV(1)Q, FEV1/height(2), FEV1 z -scores and FEV1 % predicted. Analyses were stratified by race. Results Among 7182 individuals from NHANES III and 7149 from UNOS, 1907 (27%) and 991 (14%), respectively, were Black. The lower boundary FEV1 values did not differ between Black and White individuals in either population (FEV1 first percentile difference <= 0.01 L; p>0.05). Decreasing FEV(1)Q was associated with increasing hazard ratio (HR) for mortality (NHANES III HR 1.33 (95% CI 1.28-1.39) and UNOS HR 1.18 (95% CI 1.12-1.23)). The associations were not confounded nor modified by race. Discriminative power was highest for FEV(1)Q compared with alternative FEV1 approaches in both Black and White individuals. Conclusions FEV(1)Q is an intuitive and simple race -neutral approach to interpreting FEV1 that predicts survival better than current alternative methods.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] FEV1: More Than a Measurement of Lung Function, A Biomarker of Health
    Labaki, Wassim W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209 (10) : 1181 - 1182
  • [32] FEV1 and FVC Vital Lung Function Trajectories Associated to COPD
    Olvera, N.
    Agusti, A.
    Ross, J.
    Faner, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [33] LUNG FUNCTION DYNAMIC PHENOTYPES USING NONLINEAR MODELING OF FEV1
    Conrad, D. J.
    PEDIATRIC PULMONOLOGY, 2016, 51 : 362 - 362
  • [34] Major lung resections in patients with severely compromised (FEV1&lt;40%) lung function
    Bayram, A
    Gebitekin, C
    Uzarslan, EK
    LUNG CANCER, 2005, 49 : S103 - S103
  • [35] Lung Function (FEV1) Decline and Volatile Organic Compounds (VOCs). Are VOCs Good Biomarkers for Lung Function Decline?
    Graff, S.
    Zanella, D.
    Stefanuto, P.
    Bessonov, K.
    Henket, M.
    Paulus, V.
    Guissard, F.
    Moermans, C.
    Van Steen, K.
    Focant, J.
    Louis, R.
    Schleich, F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [36] Effect Of Tiotropium On The Decline Of Lung Function In COPD Patients With Fev1 ≥ 70 %
    Lee, H.
    Choi, S.
    Lee, J.
    Park, Y.
    Lee, C.
    Kim, D.
    Yoon, H.
    Lee, S-M
    Yim, J-J
    Kim, Y.
    Han, S.
    Yoo, C-G
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [37] LUNG-FUNCTION STUDY (FEV1) OF WORKERS IN THE CHEMICAL-INDUSTRY
    HEIERLI, C
    SOZIAL-UND PRAVENTIVMEDIZIN, 1987, 32 (02): : 111 - 114
  • [38] Systemic Biomarkers of Lung Function and FEV1 Decline Across Multiple Cohorts
    Ngo, D.
    Pratte, K. A.
    Flexeder, C.
    Petersen, H.
    Dang, H.
    Ma, Y.
    Keyes, M. J.
    Petersonl, B. D.
    Sitars, V.
    Gillenwater, L. A.
    Xu, H.
    Emson, C.
    Gieger, C.
    Suhre, K.
    Graumann, J.
    Jain, D.
    Conomos, M. P.
    Tracy, R. P.
    Guo, X.
    Liu, Y.
    Johnson, W.
    Cornell, E.
    Durda, P.
    Taylor, K. D.
    Papanicolaou, G. J.
    Rich, S. S.
    Rotter, J. I.
    Rennard, S. I.
    Curtis, J. L.
    Woodruff, P.
    Comellas, A. P.
    Silverman, E. K.
    Crapo, J. D.
    Larson, M. G.
    Ramachandran, V.
    Wang, T. J.
    Gerszten, R. E.
    O'Connor, G. T.
    Barr, R.
    Couper, D.
    Dupuis, J.
    Manichaikul, A.
    O'Neal, W. K.
    Tesfaigzi, Y.
    Schulz, H.
    Bowler, R. P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [39] COPD - Development in poor Lung Function in young Adulthood and lower FEV1-Decline
    Manych, Matthias
    PNEUMOLOGIE, 2016, 70 (03): : 143 - 143
  • [40] PRELIMINARY STUDY OF REFERENCE RANGE AND FEV1 FOR NORMAL ADULT LUNG FUNCTION IN SHANGHAI
    Hu, L-J
    Zhu, L.
    Zhao, R-Y
    Zhu, W-J
    Shen, Q-J
    Li, L.
    Chen, Q.
    Yang, Y-J
    RESPIROLOGY, 2011, 16 : 282 - 283